Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients
Hiroyuki Konya,1 Yuzo Yano,1 Satoshi Matsutani,1 Taku Tsunoda,2 Takashi Ikawa,2 Yoshiki Kusunoki,2 Toshihiro Matsuo,2 Masayuki Miuchi,2 Tomoyuki Katsuno,3 Tomoya Hamaguchi,4 Jun-ichiro Miyagawa,2 Mitsuyoshi Namba21Department of Internal Medicine, Ashiya Municipal Hospital, Ashiya, 2Division of Diab...
Main Authors: | Konya H, Yano Y, Matsutani S, Tsunoda T, Ikawa T, Kusunoki Y, Matsuo T, Miuchi M, Katsuno T, Hamaguchi T, Miyagawa JI, Namba M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/profile-of-saxagliptin-in-the-treatment-of-type-2-diabetes-focus-on-ja-a17565 |
Similar Items
-
Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
by: Konya H, et al.
Published: (2013-09-01) -
Saxagliptin for type 2 diabetes
by: Antonio R Chacra, et al.
Published: (2010-09-01) -
Saxagliptin for type 2 diabetes
by: Chacra
Published: (2010-09-01) -
Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
by: Yu H, et al.
Published: (2017-07-01) -
The new drug saxagliptin is now registrated in Russia
by: Editorial team Diabetes Mellitus
Published: (2010-12-01)